Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO83 | Saccharina angustata | Species | Laminariaceae | Eukaryota | UNPD* | |||
NPO18897 | Cephalosporium gregatum | Species | NA | Eukaryota | UNPD* | |||
NPO19489 | Tylosema esculentum | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO16032 | Xanthoparmelia quintaria | Species | Parmeliaceae | Eukaryota | UNPD* | |||
NPO17868 | Eucryphia glutinosa | Species | Cunoniaceae | Eukaryota | UNPD* | |||
NPO18402 | Tecoma peroba | Species | Bignoniaceae | Eukaryota | UNPD* | |||
NPO19680 | Haminoea orteai | Species | Haminoeidae | Eukaryota | UNPD* | |||
NPO17983 | Nigrosabulum globosum | Species | Bionectriaceae | Eukaryota | UNPD* | |||
NPO13657 | Peperomia pellucida | Species | Piperaceae | Eukaryota | UNPD* | |||
NPO16452 | Iochroma coccineum | Species | Solanaceae | Eukaryota | UNPD* | |||
NPO16708 | Pinus abies | Species | Pinaceae | Eukaryota | UNPD* | |||
NPO14518 | Ateleia herbert-smithii | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO18972 | Astropecten indicus | Species | Astropectinidae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT605 | Organism | Homo sapiens | Homo sapiens | IC50 | = | 2130 | nM | 11212091 |
NPT605 | Organism | Homo sapiens | Homo sapiens | IC50 | = | 1700 | nM | 11212091 |
NPT81 | Cell Line | A549 | Homo sapiens | EC50 | > | 10 | ug/ml | 8387598 |
NPT180 | Cell Line | HCT-8 | Homo sapiens | EC50 | > | 10 | ug/ml | 8387598 |
NPT91 | Cell Line | KB | Homo sapiens | EC50 | > | 10 | ug/ml | 8387598 |
NPT168 | Cell Line | P388 | Mus musculus | EC50 | = | 4.5 | ug/ml | 8387598 |
NPT1868 | Cell Line | L1210 (1565) | EC50 | > | 10 | ug/ml | 8387598 | |
NPT1208 | Organism | Leishmania braziliensis | Leishmania braziliensis | IC90 | = | 50 | ug/ml | 10.1021/np50099a013 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC90 | = | 100 | ug/ml | 10.1021/np50099a013 |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 11220.2 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 20596.2 | nM | PubChem BioAssay data set | |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Potency | = | 8912.5 | nM | PubChem BioAssay data set |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Kd | > | 1000000 | nM | 21183345 | |
NPT532 | Individual Protein | Lysine-specific demethylase 4A | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 56234.1 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT804 | Cell Line | HT-22 | Mus musculus | EC50 | = | 750 | nM | 22192055 |
NPT848 | Cell Line | N9 | Homo sapiens | Activity | = | 6 | % | 22192055 |
NPT2 | Others | Unspecified | Activity | = | 0.12 | equiv | 22192055 | |
NPT2 | Others | Unspecified | Potency | 4466.8 | nM | PubChem BioAssay data set | ||
NPT101 | Individual Protein | Glucagon-like peptide 1 receptor | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set | |
NPT790 | Organism | Mycobacterium tuberculosis H37Rv | Mycobacterium tuberculosis H37Rv | MIC | = | 16 | ug/ml | 22280816 |
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC26850 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9658 | High Similarity | NPC26872 |
0.9051 | High Similarity | NPC312872 |
0.9026 | High Similarity | NPC177404 |
0.8846 | High Similarity | NPC118511 |
0.8788 | High Similarity | NPC204385 |
0.8704 | High Similarity | NPC283152 |
0.8659 | High Similarity | NPC206201 |
0.8642 | High Similarity | NPC288943 |
0.8443 | Intermediate Similarity | NPC62069 |
0.8402 | Intermediate Similarity | NPC66083 |
0.8373 | Intermediate Similarity | NPC222592 |
0.8373 | Intermediate Similarity | NPC168486 |
0.8284 | Intermediate Similarity | NPC42591 |
0.8225 | Intermediate Similarity | NPC84478 |
0.817 | Intermediate Similarity | NPC60553 |
0.8137 | Intermediate Similarity | NPC285635 |
0.8095 | Intermediate Similarity | NPC472168 |
0.809 | Intermediate Similarity | NPC329747 |
0.8079 | Intermediate Similarity | NPC72211 |
0.8068 | Intermediate Similarity | NPC70259 |
0.8059 | Intermediate Similarity | NPC176127 |
0.8035 | Intermediate Similarity | NPC242928 |
0.8023 | Intermediate Similarity | NPC70956 |
0.8023 | Intermediate Similarity | NPC267928 |
0.8023 | Intermediate Similarity | NPC243834 |
0.8011 | Intermediate Similarity | NPC131017 |
0.8011 | Intermediate Similarity | NPC205934 |
0.8011 | Intermediate Similarity | NPC43787 |
0.8011 | Intermediate Similarity | NPC285558 |
0.8 | Intermediate Similarity | NPC114335 |
0.8 | Intermediate Similarity | NPC474798 |
0.8 | Intermediate Similarity | NPC141915 |
0.8 | Intermediate Similarity | NPC280964 |
0.7989 | Intermediate Similarity | NPC11017 |
0.7955 | Intermediate Similarity | NPC79293 |
0.7955 | Intermediate Similarity | NPC279401 |
0.7898 | Intermediate Similarity | NPC133140 |
0.7898 | Intermediate Similarity | NPC195268 |
0.7892 | Intermediate Similarity | NPC1527 |
0.7889 | Intermediate Similarity | NPC19872 |
0.7857 | Intermediate Similarity | NPC223427 |
0.7857 | Intermediate Similarity | NPC162484 |
0.7845 | Intermediate Similarity | NPC476044 |
0.7845 | Intermediate Similarity | NPC267423 |
0.7845 | Intermediate Similarity | NPC232727 |
0.7844 | Intermediate Similarity | NPC477888 |
0.7814 | Intermediate Similarity | NPC16452 |
0.7814 | Intermediate Similarity | NPC36229 |
0.7814 | Intermediate Similarity | NPC476581 |
0.7802 | Intermediate Similarity | NPC475112 |
0.7802 | Intermediate Similarity | NPC291535 |
0.7802 | Intermediate Similarity | NPC475085 |
0.7798 | Intermediate Similarity | NPC258773 |
0.7796 | Intermediate Similarity | NPC167860 |
0.7796 | Intermediate Similarity | NPC123976 |
0.7791 | Intermediate Similarity | NPC118776 |
0.779 | Intermediate Similarity | NPC329793 |
0.779 | Intermediate Similarity | NPC234197 |
0.7784 | Intermediate Similarity | NPC44161 |
0.7784 | Intermediate Similarity | NPC470931 |
0.7751 | Intermediate Similarity | NPC474409 |
0.7747 | Intermediate Similarity | NPC470586 |
0.7738 | Intermediate Similarity | NPC476518 |
0.7735 | Intermediate Similarity | NPC4071 |
0.7735 | Intermediate Similarity | NPC476582 |
0.7735 | Intermediate Similarity | NPC476578 |
0.7733 | Intermediate Similarity | NPC478032 |
0.7727 | Intermediate Similarity | NPC296527 |
0.7705 | Intermediate Similarity | NPC199277 |
0.7705 | Intermediate Similarity | NPC295898 |
0.7705 | Intermediate Similarity | NPC135887 |
0.7692 | Intermediate Similarity | NPC176538 |
0.7692 | Intermediate Similarity | NPC14651 |
0.7692 | Intermediate Similarity | NPC121658 |
0.7692 | Intermediate Similarity | NPC315957 |
0.7688 | Intermediate Similarity | NPC475910 |
0.7688 | Intermediate Similarity | NPC287208 |
0.7684 | Intermediate Similarity | NPC471593 |
0.7684 | Intermediate Similarity | NPC76748 |
0.7676 | Intermediate Similarity | NPC476106 |
0.7676 | Intermediate Similarity | NPC472111 |
0.7676 | Intermediate Similarity | NPC304183 |
0.7667 | Intermediate Similarity | NPC13880 |
0.7655 | Intermediate Similarity | NPC54102 |
0.7655 | Intermediate Similarity | NPC162689 |
0.765 | Intermediate Similarity | NPC31930 |
0.7647 | Intermediate Similarity | NPC174672 |
0.7647 | Intermediate Similarity | NPC469589 |
0.7647 | Intermediate Similarity | NPC174758 |
0.7647 | Intermediate Similarity | NPC111624 |
0.764 | Intermediate Similarity | NPC92111 |
0.764 | Intermediate Similarity | NPC469390 |
0.7637 | Intermediate Similarity | NPC128823 |
0.7637 | Intermediate Similarity | NPC287437 |
0.7634 | Intermediate Similarity | NPC193777 |
0.7625 | Intermediate Similarity | NPC161292 |
0.7622 | Intermediate Similarity | NPC47059 |
0.7622 | Intermediate Similarity | NPC118832 |
0.7622 | Intermediate Similarity | NPC329708 |
0.7622 | Intermediate Similarity | NPC274291 |
0.7622 | Intermediate Similarity | NPC264166 |
0.7622 | Intermediate Similarity | NPC165349 |
0.7614 | Intermediate Similarity | NPC61350 |
0.7596 | Intermediate Similarity | NPC477019 |
0.7586 | Intermediate Similarity | NPC144114 |
0.7584 | Intermediate Similarity | NPC122718 |
0.7568 | Intermediate Similarity | NPC475774 |
0.7568 | Intermediate Similarity | NPC245816 |
0.7568 | Intermediate Similarity | NPC476138 |
0.7566 | Intermediate Similarity | NPC208284 |
0.7558 | Intermediate Similarity | NPC473432 |
0.7557 | Intermediate Similarity | NPC94943 |
0.7556 | Intermediate Similarity | NPC307963 |
0.7556 | Intermediate Similarity | NPC475190 |
0.7553 | Intermediate Similarity | NPC201697 |
0.7544 | Intermediate Similarity | NPC208060 |
0.7543 | Intermediate Similarity | NPC212535 |
0.754 | Intermediate Similarity | NPC4687 |
0.754 | Intermediate Similarity | NPC249583 |
0.7531 | Intermediate Similarity | NPC288445 |
0.7528 | Intermediate Similarity | NPC110741 |
0.7527 | Intermediate Similarity | NPC164374 |
0.7527 | Intermediate Similarity | NPC137929 |
0.7527 | Intermediate Similarity | NPC470930 |
0.7526 | Intermediate Similarity | NPC202768 |
0.7526 | Intermediate Similarity | NPC296482 |
0.7526 | Intermediate Similarity | NPC264176 |
0.7526 | Intermediate Similarity | NPC202605 |
0.7526 | Intermediate Similarity | NPC53069 |
0.7526 | Intermediate Similarity | NPC112206 |
0.7517 | Intermediate Similarity | NPC148140 |
0.7514 | Intermediate Similarity | NPC194040 |
0.7514 | Intermediate Similarity | NPC314573 |
0.7514 | Intermediate Similarity | NPC66815 |
0.7513 | Intermediate Similarity | NPC269367 |
0.7513 | Intermediate Similarity | NPC471304 |
0.7513 | Intermediate Similarity | NPC470020 |
0.75 | Intermediate Similarity | NPC82548 |
0.75 | Intermediate Similarity | NPC320394 |
0.75 | Intermediate Similarity | NPC190007 |
0.7487 | Intermediate Similarity | NPC471080 |
0.7487 | Intermediate Similarity | NPC469592 |
0.7474 | Intermediate Similarity | NPC213530 |
0.7474 | Intermediate Similarity | NPC193267 |
0.7473 | Intermediate Similarity | NPC251090 |
0.7471 | Intermediate Similarity | NPC72980 |
0.7471 | Intermediate Similarity | NPC88363 |
0.7468 | Intermediate Similarity | NPC280853 |
0.7466 | Intermediate Similarity | NPC81561 |
0.746 | Intermediate Similarity | NPC473181 |
0.7457 | Intermediate Similarity | NPC56618 |
0.7457 | Intermediate Similarity | NPC84347 |
0.7447 | Intermediate Similarity | NPC313189 |
0.7446 | Intermediate Similarity | NPC18487 |
0.7439 | Intermediate Similarity | NPC153769 |
0.7435 | Intermediate Similarity | NPC48353 |
0.7435 | Intermediate Similarity | NPC171409 |
0.7435 | Intermediate Similarity | NPC472098 |
0.7435 | Intermediate Similarity | NPC96405 |
0.7427 | Intermediate Similarity | NPC314940 |
0.7427 | Intermediate Similarity | NPC473764 |
0.7423 | Intermediate Similarity | NPC473041 |
0.7421 | Intermediate Similarity | NPC285016 |
0.7421 | Intermediate Similarity | NPC245657 |
0.7421 | Intermediate Similarity | NPC199667 |
0.7409 | Intermediate Similarity | NPC152768 |
0.7409 | Intermediate Similarity | NPC274982 |
0.7409 | Intermediate Similarity | NPC148183 |
0.7405 | Intermediate Similarity | NPC121772 |
0.7405 | Intermediate Similarity | NPC471596 |
0.7396 | Intermediate Similarity | NPC159319 |
0.7396 | Intermediate Similarity | NPC478074 |
0.7394 | Intermediate Similarity | NPC45190 |
0.7394 | Intermediate Similarity | NPC323345 |
0.7394 | Intermediate Similarity | NPC470164 |
0.7394 | Intermediate Similarity | NPC300156 |
0.7391 | Intermediate Similarity | NPC471598 |
0.7386 | Intermediate Similarity | NPC266551 |
0.7386 | Intermediate Similarity | NPC161887 |
0.7386 | Intermediate Similarity | NPC219963 |
0.7386 | Intermediate Similarity | NPC477891 |
0.7386 | Intermediate Similarity | NPC470474 |
0.7382 | Intermediate Similarity | NPC87413 |
0.738 | Intermediate Similarity | NPC469440 |
0.7371 | Intermediate Similarity | NPC305984 |
0.7368 | Intermediate Similarity | NPC278874 |
0.7368 | Intermediate Similarity | NPC185782 |
0.7363 | Intermediate Similarity | NPC230403 |
0.7358 | Intermediate Similarity | NPC235076 |
0.7358 | Intermediate Similarity | NPC16066 |
0.7358 | Intermediate Similarity | NPC470549 |
0.7354 | Intermediate Similarity | NPC193238 |
0.7354 | Intermediate Similarity | NPC135549 |
0.7344 | Intermediate Similarity | NPC94157 |
0.7344 | Intermediate Similarity | NPC310211 |
0.7344 | Intermediate Similarity | NPC308137 |
0.7344 | Intermediate Similarity | NPC473180 |
0.7344 | Intermediate Similarity | NPC26679 |
0.7337 | Intermediate Similarity | NPC224928 |
0.7337 | Intermediate Similarity | NPC59779 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC26850 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8667 | High Similarity | NPD5083 | Clinical (unspecified phase) |
0.8424 | Intermediate Similarity | NPD3920 | Phase 2 |
0.8324 | Intermediate Similarity | NPD6861 | Clinical (unspecified phase) |
0.8218 | Intermediate Similarity | NPD6590 | Discontinued |
0.8214 | Intermediate Similarity | NPD4203 | Approved |
0.8214 | Intermediate Similarity | NPD4204 | Approved |
0.8171 | Intermediate Similarity | NPD4724 | Clinical (unspecified phase) |
0.8171 | Intermediate Similarity | NPD6550 | Discontinued |
0.8114 | Intermediate Similarity | NPD6491 | Clinical (unspecified phase) |
0.8092 | Intermediate Similarity | NPD2410 | Phase 2 |
0.8068 | Intermediate Similarity | NPD5512 | Phase 3 |
0.8023 | Intermediate Similarity | NPD6988 | Phase 1 |
0.8023 | Intermediate Similarity | NPD6769 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD6872 | Clinical (unspecified phase) |
0.7987 | Intermediate Similarity | NPD2882 | Phase 1 |
0.7967 | Intermediate Similarity | NPD6150 | Discontinued |
0.7965 | Intermediate Similarity | NPD4889 | Approved |
0.7933 | Intermediate Similarity | NPD4118 | Clinical (unspecified phase) |
0.7901 | Intermediate Similarity | NPD5669 | Clinical (unspecified phase) |
0.7898 | Intermediate Similarity | NPD3923 | Approved |
0.7898 | Intermediate Similarity | NPD3924 | Approved |
0.7898 | Intermediate Similarity | NPD6569 | Phase 2 |
0.7898 | Intermediate Similarity | NPD3922 | Approved |
0.7898 | Intermediate Similarity | NPD3921 | Approved |
0.7895 | Intermediate Similarity | NPD7414 | Clinical (unspecified phase) |
0.788 | Intermediate Similarity | NPD5658 | Approved |
0.7875 | Intermediate Similarity | NPD6158 | Phase 2 |
0.7875 | Intermediate Similarity | NPD6476 | Clinical (unspecified phase) |
0.7824 | Intermediate Similarity | NPD6159 | Phase 2 |
0.7809 | Intermediate Similarity | NPD4418 | Discontinued |
0.7809 | Intermediate Similarity | NPD6251 | Discontinued |
0.7802 | Intermediate Similarity | NPD6208 | Discontinued |
0.7791 | Intermediate Similarity | NPD3386 | Phase 2 |
0.7778 | Intermediate Similarity | NPD1503 | Clinical (unspecified phase) |
0.7772 | Intermediate Similarity | NPD4305 | Clinical (unspecified phase) |
0.7772 | Intermediate Similarity | NPD5530 | Phase 1 |
0.7765 | Intermediate Similarity | NPD3478 | Clinical (unspecified phase) |
0.7765 | Intermediate Similarity | NPD3477 | Phase 2 |
0.776 | Intermediate Similarity | NPD6991 | Approved |
0.7746 | Intermediate Similarity | NPD5522 | Clinical (unspecified phase) |
0.773 | Intermediate Similarity | NPD5429 | Discontinued |
0.773 | Intermediate Similarity | NPD7222 | Phase 2 |
0.7719 | Intermediate Similarity | NPD3503 | Approved |
0.7719 | Intermediate Similarity | NPD3504 | Approved |
0.7717 | Intermediate Similarity | NPD4795 | Phase 2 |
0.7709 | Intermediate Similarity | NPD3324 | Clinical (unspecified phase) |
0.7697 | Intermediate Similarity | NPD112 | Approved |
0.7697 | Intermediate Similarity | NPD4372 | Phase 1 |
0.7697 | Intermediate Similarity | NPD9705 | Discontinued |
0.7692 | Intermediate Similarity | NPD1740 | Approved |
0.7692 | Intermediate Similarity | NPD1739 | Approved |
0.7676 | Intermediate Similarity | NPD3003 | Approved |
0.7665 | Intermediate Similarity | NPD2782 | Approved |
0.7665 | Intermediate Similarity | NPD2780 | Approved |
0.766 | Intermediate Similarity | NPD6567 | Clinical (unspecified phase) |
0.7654 | Intermediate Similarity | NPD1304 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD32 | Approved |
0.7622 | Intermediate Similarity | NPD31 | Approved |
0.7622 | Intermediate Similarity | NPD4122 | Approved |
0.7622 | Intermediate Similarity | NPD4036 | Approved |
0.7622 | Intermediate Similarity | NPD4033 | Approved |
0.7622 | Intermediate Similarity | NPD4039 | Approved |
0.7622 | Intermediate Similarity | NPD4038 | Approved |
0.7622 | Intermediate Similarity | NPD4037 | Approved |
0.7622 | Intermediate Similarity | NPD4034 | Approved |
0.7622 | Intermediate Similarity | NPD4035 | Approved |
0.7611 | Intermediate Similarity | NPD3810 | Clinical (unspecified phase) |
0.7594 | Intermediate Similarity | NPD7672 | Approved |
0.7594 | Intermediate Similarity | NPD7671 | Approved |
0.7581 | Intermediate Similarity | NPD3842 | Clinical (unspecified phase) |
0.7574 | Intermediate Similarity | NPD2781 | Approved |
0.7571 | Intermediate Similarity | NPD6257 | Clinical (unspecified phase) |
0.7571 | Intermediate Similarity | NPD2749 | Discontinued |
0.7562 | Intermediate Similarity | NPD1305 | Clinical (unspecified phase) |
0.7558 | Intermediate Similarity | NPD4354 | Approved |
0.7556 | Intermediate Similarity | NPD1038 | Approved |
0.7542 | Intermediate Similarity | NPD2334 | Discontinued |
0.7541 | Intermediate Similarity | NPD3825 | Phase 3 |
0.754 | Intermediate Similarity | NPD7452 | Approved |
0.754 | Intermediate Similarity | NPD7453 | Approved |
0.7527 | Intermediate Similarity | NPD4673 | Phase 2 |
0.7526 | Intermediate Similarity | NPD3816 | Phase 1 |
0.7526 | Intermediate Similarity | NPD7069 | Discontinued |
0.7526 | Intermediate Similarity | NPD3815 | Phase 1 |
0.7514 | Intermediate Similarity | NPD3396 | Approved |
0.7514 | Intermediate Similarity | NPD3395 | Approved |
0.7485 | Intermediate Similarity | NPD5680 | Clinical (unspecified phase) |
0.7474 | Intermediate Similarity | NPD4502 | Phase 2 |
0.7474 | Intermediate Similarity | NPD5416 | Discontinued |
0.7474 | Intermediate Similarity | NPD6220 | Phase 3 |
0.747 | Intermediate Similarity | NPD2582 | Approved |
0.747 | Intermediate Similarity | NPD2581 | Approved |
0.7461 | Intermediate Similarity | NPD7823 | Clinical (unspecified phase) |
0.7458 | Intermediate Similarity | NPD7424 | Clinical (unspecified phase) |
0.7448 | Intermediate Similarity | NPD5902 | Approved |
0.7448 | Intermediate Similarity | NPD5417 | Clinical (unspecified phase) |
0.7448 | Intermediate Similarity | NPD5903 | Approved |
0.7448 | Intermediate Similarity | NPD6140 | Clinical (unspecified phase) |
0.7446 | Intermediate Similarity | NPD1768 | Approved |
0.7436 | Intermediate Similarity | NPD5930 | Phase 3 |
0.7432 | Intermediate Similarity | NPD4899 | Clinical (unspecified phase) |
0.7425 | Intermediate Similarity | NPD6060 | Clinical (unspecified phase) |
0.7416 | Intermediate Similarity | NPD4375 | Approved |
0.7416 | Intermediate Similarity | NPD2917 | Approved |
0.7416 | Intermediate Similarity | NPD5256 | Discontinued |
0.7399 | Intermediate Similarity | NPD1923 | Clinical (unspecified phase) |
0.7394 | Intermediate Similarity | NPD8403 | Phase 1 |
0.7385 | Intermediate Similarity | NPD7194 | Discontinued |
0.7384 | Intermediate Similarity | NPD1078 | Clinical (unspecified phase) |
0.7382 | Intermediate Similarity | NPD5066 | Phase 2 |
0.7382 | Intermediate Similarity | NPD5067 | Phase 2 |
0.7371 | Intermediate Similarity | NPD1620 | Clinical (unspecified phase) |
0.7371 | Intermediate Similarity | NPD3440 | Clinical (unspecified phase) |
0.7365 | Intermediate Similarity | NPD4669 | Clinical (unspecified phase) |
0.7365 | Intermediate Similarity | NPD4671 | Clinical (unspecified phase) |
0.7365 | Intermediate Similarity | NPD4670 | Clinical (unspecified phase) |
0.736 | Intermediate Similarity | NPD6344 | Clinical (unspecified phase) |
0.7351 | Intermediate Similarity | NPD4548 | Discontinued |
0.7344 | Intermediate Similarity | NPD4927 | Discontinued |
0.734 | Intermediate Similarity | NPD3397 | Phase 2 |
0.7337 | Intermediate Similarity | NPD1684 | Approved |
0.7337 | Intermediate Similarity | NPD1685 | Approved |
0.7329 | Intermediate Similarity | NPD3525 | Discontinued |
0.7318 | Intermediate Similarity | NPD4921 | Phase 3 |
0.7318 | Intermediate Similarity | NPD4919 | Phase 3 |
0.7318 | Intermediate Similarity | NPD4920 | Clinical (unspecified phase) |
0.7316 | Intermediate Similarity | NPD5529 | Phase 1 |
0.7316 | Intermediate Similarity | NPD5528 | Clinical (unspecified phase) |
0.7314 | Intermediate Similarity | NPD5670 | Approved |
0.7314 | Intermediate Similarity | NPD4072 | Approved |
0.7314 | Intermediate Similarity | NPD4071 | Approved |
0.7312 | Intermediate Similarity | NPD4396 | Clinical (unspecified phase) |
0.7299 | Intermediate Similarity | NPD6492 | Phase 2 |
0.7278 | Intermediate Similarity | NPD1034 | Phase 3 |
0.7278 | Intermediate Similarity | NPD2383 | Phase 1 |
0.7278 | Intermediate Similarity | NPD1033 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD6592 | Clinical (unspecified phase) |
0.7268 | Intermediate Similarity | NPD7538 | Clinical (unspecified phase) |
0.7259 | Intermediate Similarity | NPD5070 | Clinical (unspecified phase) |
0.7245 | Intermediate Similarity | NPD6985 | Discontinued |
0.7245 | Intermediate Similarity | NPD4429 | Discontinued |
0.7245 | Intermediate Similarity | NPD7395 | Discontinued |
0.7241 | Intermediate Similarity | NPD6607 | Clinical (unspecified phase) |
0.7232 | Intermediate Similarity | NPD2601 | Approved |
0.7232 | Intermediate Similarity | NPD2599 | Approved |
0.7232 | Intermediate Similarity | NPD2600 | Approved |
0.7216 | Intermediate Similarity | NPD5751 | Clinical (unspecified phase) |
0.7216 | Intermediate Similarity | NPD4457 | Phase 2 |
0.7208 | Intermediate Similarity | NPD3763 | Approved |
0.7204 | Intermediate Similarity | NPD2727 | Phase 2 |
0.7202 | Intermediate Similarity | NPD7468 | Clinical (unspecified phase) |
0.72 | Intermediate Similarity | NPD9690 | Approved |
0.7198 | Intermediate Similarity | NPD6281 | Approved |
0.7186 | Intermediate Similarity | NPD6824 | Clinical (unspecified phase) |
0.7179 | Intermediate Similarity | NPD3257 | Approved |
0.7173 | Intermediate Similarity | NPD1392 | Approved |
0.7169 | Intermediate Similarity | NPD3833 | Phase 3 |
0.7169 | Intermediate Similarity | NPD3835 | Phase 3 |
0.7164 | Intermediate Similarity | NPD7676 | Clinical (unspecified phase) |
0.7164 | Intermediate Similarity | NPD7674 | Phase 3 |
0.7164 | Intermediate Similarity | NPD7675 | Phase 3 |
0.7164 | Intermediate Similarity | NPD7426 | Phase 1 |
0.7158 | Intermediate Similarity | NPD5912 | Clinical (unspecified phase) |
0.7158 | Intermediate Similarity | NPD1924 | Approved |
0.7158 | Intermediate Similarity | NPD3946 | Clinical (unspecified phase) |
0.7158 | Intermediate Similarity | NPD5913 | Phase 3 |
0.7157 | Intermediate Similarity | NPD5632 | Approved |
0.7152 | Intermediate Similarity | NPD3385 | Approved |
0.7151 | Intermediate Similarity | NPD2952 | Discontinued |
0.715 | Intermediate Similarity | NPD7548 | Discontinued |
0.7143 | Intermediate Similarity | NPD6147 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD6477 | Clinical (unspecified phase) |
0.7135 | Intermediate Similarity | NPD2187 | Approved |
0.7135 | Intermediate Similarity | NPD2739 | Clinical (unspecified phase) |
0.7135 | Intermediate Similarity | NPD2189 | Approved |
0.7135 | Intermediate Similarity | NPD3853 | Clinical (unspecified phase) |
0.7135 | Intermediate Similarity | NPD5863 | Clinical (unspecified phase) |
0.7128 | Intermediate Similarity | NPD6219 | Discontinued |
0.7121 | Intermediate Similarity | NPD3875 | Discontinued |
0.7115 | Intermediate Similarity | NPD947 | Approved |
0.7114 | Intermediate Similarity | NPD6246 | Approved |
0.7113 | Intermediate Similarity | NPD7703 | Clinical (unspecified phase) |
0.7112 | Intermediate Similarity | NPD7889 | Clinical (unspecified phase) |
0.7105 | Intermediate Similarity | NPD6324 | Phase 1 |
0.7105 | Intermediate Similarity | NPD5513 | Phase 2 |
0.7102 | Intermediate Similarity | NPD5065 | Approved |
0.71 | Intermediate Similarity | NPD1954 | Phase 1 |
0.71 | Intermediate Similarity | NPD7221 | Approved |
0.71 | Intermediate Similarity | NPD7219 | Approved |
0.7095 | Intermediate Similarity | NPD3037 | Phase 1 |
0.7092 | Intermediate Similarity | NPD5293 | Phase 2 |
0.7086 | Intermediate Similarity | NPD6739 | Clinical (unspecified phase) |
0.7085 | Intermediate Similarity | NPD6242 | Discontinued |
0.7085 | Intermediate Similarity | NPD7678 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD6357 | Discontinued |
0.7081 | Intermediate Similarity | NPD6361 | Phase 2 |
0.7081 | Intermediate Similarity | NPD4551 | Phase 2 |
0.7081 | Intermediate Similarity | NPD5575 | Clinical (unspecified phase) |
0.7079 | Intermediate Similarity | NPD5398 | Clinical (unspecified phase) |
0.7077 | Intermediate Similarity | NPD6202 | Discontinued |
PubChem CID   | 826247 |
ChEMBL   | CHEMBL279335 |
ZINC   |
Molecular Weight:   | 235.10 |
ALogP:   | -0.0518 |
MLogP:   | 3 |
XLogP:   | 5.566 |
# Rotatable Bonds:   | 3 |
Polar Surface Area:   | 22.12 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 0 |
# Rings:   | 3 |
# Heavy Atoms:   | 18 |